Company Overview of Vasotissue Technologies GmbH
Vasotissue Technologies GmbH develops, produces, and markets endothelialised bypass grafts. It provides cell cultures, perfusion chambers, and perfusion culture systems. Vasotissue Technologies GmbH was formerly known as Cell-Lining GmbH. The company was founded in 1996 and is based in Berlin, Germany. As of August 21, 2002, Vasotissue Technologies GmbH operates as a subsidiary of BioTissue Technologies AG.
Founded in 1996
49 30 450 57 81 93
49 30 450 51 39 57
Key Executives for Vasotissue Technologies GmbH
Similar Private Companies By Industry
|4 Animals AlsterScience GmbH||Europe|
|Acousia Therapeutics GmbH||Europe|
|Across Barriers GmbH||Europe|
|Actinodrug Pharmaceuticals GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Vasotissue Technologies GmbH, please visit www.vasotissue.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.